Proteasome Inhibition by Fellutamide B Induces Nerve Growth Factor Synthesis

Chemistry and Biology

Volumn 15, Issue 5, 2008, Pages 501-512

  Hines, John ^a   Groll, Michael ^b   Fahnestock, Margaret ^c   Crews, Craig M ^a,d  

^a YALE UNIVERSITY   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c MCMASTER UNIVERSITY   (Canada)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CHEMBIO; MOLNEURO; PROTEINS

Indexed keywords

PENICILLIUM; PENICILLIUM FELLUTANUM;

EID: 43149103265     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2008.03.020     Document Type: Article

References (47)

1. L. Borissenko M. Groll 20S proteasome and its inhibitors: crystallographic knowledge for drug development Chem. Rev. 107 2007 687 717
2. A.T. Brünger Assessment of phase accuracy by cross validation: the free R value. Methods and applications Acta Crystallogr. D Biol. Crystallogr. 49 1993 24 36
3. A.T. Brünger P.D. Adams G.M. Clore W.L. DeLano P. Gros R.W. Grosse-Kunstleve J.S. Jiang J. Kuszewski M. Nilges N.S. Pannu Crystallography & NMR system: a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54 1998 905 921
4. M.R. Castellanos-Ortega R. Cruz-Aguado L. Martinez-Martí Nerve growth factor: possibilities and limitations of its clinical application Rev. Neurol. 29 1999 439 447
5. R.K. Chaturvedi S. Shukla K. Seth A.K. Agrawal Nerve growth factor increases survival of dopaminergic graft, rescue of nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease Neurosci. Lett. 398 2006 44 49
6. Y. Cheng B. Schneider U. Riese B. Schubert Z. Li M. Hamburger (+)-N-Deoxymilitarinone A, a neuritogenic pyridone alkaloid from the insect pathogenic fungus, Paecilomyces farinosus J. Nat. Prod. 69 2006 436 438
7. S.R. D'Mello G. Heinrich Structural and functional identification of regulatory regions and cis elements surrounding the nerve growth factor gene promoter Brain Res. Mol. Brain Res. 11 1991 255 264
8. G. Fenteany R.F. Standaert G.A. Reichard E.J. Corey S.L. Schreiber A β-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcome cell line Proc. Natl. Acad. Sci. USA 91 1994 3358 3362
9. L. Fioriti S. Dossena L.R. Stewart R.S. Stewart D.A. Harris G. Forloni R. Chiesa Cytosolic prion protein (PrP) is not toxic in N2A cells and primary neurons expressing pathogenic PrP mutations J. Biol. Chem. 280 2005 11320 11328
10. I.R. Garrett D. Chen G. Gutierrez M. Zhao A. Escobedo G. Rossini S.E. Harris W. Gallwitz K.B. Kim S. Hu Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro J. Clin. Invest. 111 2003 1771 1782
11. M. Groll R. Huber Purification, crystallization and X-ray analysis of the yeast 20S proteasomes Methods Enzymol. 398 2005 329 336
12. M. Groll L. Ditzel J. Lowe D. Stock M. Bochtler H.D. Bartunik R. Huber Structure of 20S proteasome from yeast at 2.4 Å resolution Nature 386 1997 463 471
13. E.J. Huang L.F. Reichardt Trk receptors: roles in neuronal signal transduction Annu. Rev. Biochem. 72 2003 609 642
14. M. Inoue H. Zhai H. Sakazaki H. Furuyama Y. Fukuyama M. Hirama TMC-95A, a reversible proteasome inhibitor, induces neurite outgrowth in PC12 cells Bioorg. Med. Chem. Lett. 14 2004 663 665
15. K.-B. Kim F.N. Fonseca C.M. Crews Development and characterization of proteasome inhibitors R.J. Deshaies Methods in Enzymology Volume 399 2005 Elsevier Academic Press London, U.K. 585 609
16. M. Kristiansen M.J. Messenger P.-C. Klöhn S. Brandner J.D.F. Wadsworth J. Collinge S.J. Tabrizi Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis J. Biol. Chem. 280 2005 38851 38861
17. P.A. Lapchak Nerve growth factor pharmacology: application to the treatment of choliergic neurodegeneration in Alzheimer's disease Exp. Neurol. 124 1993 16 20
18. G.S. Liao X.B. Li C.Y. Zhang Y.Y. Shu S.X. Tang Pharmacological actions of nerve growth factor-transferrin conjugate on the central nervous system J. Nat. Toxins 10 2001 291 297
19. C. Lindenthal N. Weich Y.S. Chia V. Heussler M.Q. Klinkert The proteasome inhibitor MLN-273 blocks exoerythrocytic and erythrocytic development of Plasmodium parasites Parasitology 131 2005 37 44
20. G. Loidl M. Groll H.J. Musiol R. Huber L. Moroder Bivalency as a principle for proteasome inhibition Proc. Natl. Acad. Sci. USA 96 1999 5418 5422
21. J. Löwe D. Stock B. Jap P. Zwicki W. Baumeister R. Huber Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution Science 268 1995 533 539
22. J. Ma S. Lindquist Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation Proc. Natl. Acad. Sci. USA 98 2001 14955 14960
23. B.L. MacInnis R.B. Campenot Regulation of Wallerian degeneration and nerve growth factor withdrawal-induced pruning of axons of sympathetic neurons by the proteasome and the MEK/Erk pathway Mol. Cell. Neurosci. 28 2005 430 439
24. P.C. Maisonpierre L. Belluscio B. Friedman R.F. Alderson S.J. Wiegand M.E. Furth R.M. Lindsay G.D. Yancopoulos NT-3, BDNF and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression Neuron 5 1990 501 509
25. L. Meng B.H.B. Kwok N. Sin C.M. Crews Eponemycin exerts its antitumor effect through the inhibition of proteasome function Cancer Res. 59 1999 2798 2801
26. L. Meng R. Mohan B.H.B. Kwok M. Elofsson N. Sin C.M. Crews Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity Proc. Natl. Acad. Sci. USA 96 1999 10403 10408
27. J. Myung K.B. Kim K. Lindsten N.P. Dantuma C.M. Crews Lack of proteasome active site allostery as revealed by subunit-specific inhibitors Mol. Cell 7 2001 411 420
28. M. Obin E. Mesco X. Gong A.L. Haas J. Joseph A. Taylor Neurite outgrowth in PC12 cells J. Biol. Chem. 274 1999 11789 11795
29. E. Omae T. Katsumata M. Sakuma Y. Furukawa S. Furukawa Prolonged alkylcatechol-induced expression of c-Jun proto-oncongene followed by elevation of NGF mRNA in cultured astroglial cells J. Neurosci. Res. 39 1994 290 297
30. Z. Otwinowski W. Minor Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 276 1997 307 326
31. Z. Otwinowski D. Borek W. Majewski W. Minor Multiparametric scaling of diffraction intensities Acta Crystallogr. A 59 2003 228 234
32. J.B. Phillips A.J. Williams J. Adams P.J. Elliott F.C. Tortella Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia Stroke 31 2000 1686 1693
33. M.M. Racke P.J. Mason M.P. Johnson R.G. Brankamp M.D. Linnik Demonstration of a second pharmacologically active promoter region in the NGF gene that induces transcription at exon 3 Brain Res. Mol. Brain Res. 41 1996 192 199
34. X. Roucou Q. Guo Y. Zhang C.G. Goodyer A. LeBlanc Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons J. Biol. Chem. 278 2003 40877 40881
35. J.S. Schneekloth J.L. Sanders J. Hines C.M. Crews Neurotrophic peptide aldehydes: solid phase synthesis of fellutamide B and a simplified analog Bioorg. Med. Chem. Lett. 16 2006 3855 3858
36. H. Shigemori S. Wakuri K. Yazawa T. Nakamura T. Sasaki J.I. Kobayashi Fellutamides A and B, cytotoxic peptides from a marine fish-possessing fungus Penicillium fellutanum Tetrahedron 47 1991 8529 8534
37. N. Sin K.-B. Kim M. Elofsson L. Meng H. Auth B.H. Kwok C.M. Crews Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology Bioorg. Med. Chem. Lett. 9 1999 2283 2288
38. A.F. Straight A. Cheung J. Limouze I. Chen N.J. Westwood J.R. Sellers T.J. Mitchison Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor Science 299 2003 1743 1747
39. A. Takeda H. Onodera A. Sugimoto K. Kogure M. Obinata S. Shibahara Coordinated expression of messenger RNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 in the rat hippocampus following transient forebrain ischemia Neuroscience 55 1993 23 31
40. Turk, D. (1992) Improvement of a program for molecular graphics and manipulation of electron densities and its application for protein structure determination. Thesis in Biochemistry and Biophysics, Technische Universität Müenchen, Munich, Germany.
41. M.H. Tuszynski L. Thai M. Pay D.P. Salmon H.S. U R. Bakay P. Patel A. Blesch H.L. Vahlsing G. Ho A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease Nat. Med. 11 2005 551 555
42. T.D. Veenstra M. Fahnestock R. Kumar An AP-1 site in the nerve growth factor promoter is essential for 1,25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts Biochemistry 37 1998 5988 5994
43. J.L. Venero F. Hefti B. Knusel Trophic effect of exogenous nerve growth factor on rat striatal cholinergic neuros: comparison between intraparenchymal and intraventricular administration Mol. Pharmacol. 49 1996 303 310
44. M. Warashina K.H. Min T. Kuwabara A. Huynh F.H. Gage P.G. Schultz S. Ding A synthetic small molecule that induces neuronal differentiation of adult hippocampal neural progenitor cells Angew. Chem. Int. Ed. Engl. 45 2006 591 593
45. K. Yamaguchi T. Tsuji S. Wakuri K. Yazawa K. Kondo H. Shigemori J.I. Kobayashi Stimulation of nerve growth factor synthesis and secretion by fellutamide A in vitro Biosci. Biotechnol. Biochem. 57 1993 195 199
46. CIP/WAF for endothelial growth arrest Proc. Natl. Acad. Sci. USA 97 2000 12782 12787
47. Q. Zhai J. Wang A. Kim Q. Liu R. Watts E. Hoopfer T. Mitchison L. Luo Z. He Involvement of the ubiquitin-proteasome system in the early stages of Wallerian Degeneration Neuron 39 2003 217 225